MX9707186A - Formulacion oral de 2-metil-tieno-benzodiazepina. - Google Patents
Formulacion oral de 2-metil-tieno-benzodiazepina.Info
- Publication number
- MX9707186A MX9707186A MX9707186A MX9707186A MX9707186A MX 9707186 A MX9707186 A MX 9707186A MX 9707186 A MX9707186 A MX 9707186A MX 9707186 A MX9707186 A MX 9707186A MX 9707186 A MX9707186 A MX 9707186A
- Authority
- MX
- Mexico
- Prior art keywords
- thieno
- oral
- methyl
- formulation
- benzodiazepine formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- KHXIELCFAHVRAL-UHFFFAOYSA-N 2-methylthieno[2,3-i][1,2]benzodiazepine Chemical compound C12=NN(C)C=CC=C2C=CC2=C1C=CS2 KHXIELCFAHVRAL-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 abstract 1
- 229960005017 olanzapine Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La invencion proporciona una formulacion oral solida farmacéuticamente elegante de la olanzapina y un proceso para elaborar tal formulacion.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41046595A | 1995-03-24 | 1995-03-24 | |
| US410465 | 1995-03-24 | ||
| PCT/US1996/003918 WO1996029995A1 (en) | 1995-03-24 | 1996-03-22 | Oral 2-methyl-thieno-benzodiazepine formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9707186A true MX9707186A (es) | 1997-11-29 |
| MXPA97007186A MXPA97007186A (es) | 1998-07-03 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY113440A (en) | Oral 2-methyl-thieno-benzodiazepine formulation | |
| CA2214005A1 (en) | Process and crystal forms of 2-methyl-thieno-benzodiazepine | |
| MY125467A (en) | Olanzapine dihydrate d | |
| ZA969001B (en) | Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| AU5917796A (en) | Streptavidin mutants | |
| HU9603484D0 (en) | Pharmaceutical compositions and process for producing symptom-transduction | |
| IL137394A (en) | Hydroxyimine derivatives | |
| IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
| NO991405L (no) | Belagt partikkelformulering | |
| AU2377095A (en) | Apparatus for the manufacture of innerspring constructions | |
| MY126476A (en) | 2-methyl-thieno-benzodiazepine formulation | |
| EP0761718A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| HUP9900143A3 (en) | Pharmaceutically useful 3-pyridil-compounds | |
| HUP9903684A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating depression | |
| AU1677095A (en) | Oral dosage form of desmopressin (ddavp) | |
| AU7600396A (en) | Male contraceptive | |
| AP9801245A0 (en) | Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutants | |
| EP0761721A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| AU7508396A (en) | Shoulder implant | |
| EP0761719A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| JO1909B1 (en) | Composition of 2-methylthenio-benzodiazepine oral | |
| UA41981C2 (uk) | Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання | |
| EP0761720A3 (de) | Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden | |
| AU5872596A (en) | Method for treating anorexia | |
| AU3678495A (en) | Herbal-based oral composition and process for producing the same |